Author:
Kane John M,Aguglia Eugenio,Altamura A.Carlo,Gutierrez José Luis Ayuso,Brunello Nicoletta,Fleischhacker W.Wolfgang,Gaebel Wolfang,Gerlach Jes,Guelfi Julien-D,Kissling Werner,Lapierre Yvon D,Lindström Eva,Mendlewicz Julien,Racagni Giorgio,Carulla Luis Salvador,Schooler Nina R
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference79 articles.
1. Fluphenazine decanoate trial in chronic inpatient schizophrenics failing to absorb oral chlorpromazine;Adamson;Dis. Nerv. System,1973
2. Altamura, A.C., Colacurcio, F., Mauri, M.C. et al., 1990a. Haloperidol decanoate in chronic schizophrenia: a follow up study of 12 months with plasma levels. Prog. Neuropsychopharmacol. Biol. Psychiatry 14, 25–35.
3. Altamura, A.C., Mauri, M.C., Girardi, T., Panetta, B., 1990b. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia. Int. J. Clin. Pharmacol. Res. 10 (4), 223–228.
4. Report on the fifth consensus conference: methodology of long-term clinical trials in psychiatry;Angst;Pharmacopsychiatry,1994
5. Quality of life of schizophrenic patients on medications and implications for new drug trials;Awad;Hosp. Commun. Psychiatry,1992
Cited by
303 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献